Skip to content

French recommend immediate access to IL-2

How to use HIV/AIDS e-mail lists: an on-line introduction

Abbott answers latest Kaletra criticisms

Treatment interruptions: reassuring data

Meeting hears new data on treatment simplification

Once daily ddI: debate over US warning

Prevention funds still being wasted

Latest news from the Glasgow Drug Therapy in HIV Infection conference (Nov 8-12)

Structured treatment interruptions: best results for people with low but detectable viral load

Viral load - how low must you go?

Nevirapine out-performs nelfinavir in high viral load patients

What to do with ritonavir liquid

90% of HIV+ children die within 3 years in Africa

Developing world needs $10 billion a year AIDS help

South African judge slams pharma cos in conference keynote speech

New NNRTI halted for safety check

Common AZT mutations weaken d4T/ddI response

US face African style infection rates among young black gay men